NEWS

CPhI & P-MEC China 2022 Rescheduled to December 20-22

Due to the sudden and unexpected rise in COVID-19 cases in Shanghai and local cities, we have taken the decision to postpone the in-person CPhI & P-MEC China event from 16-18 December 2021 to 21-23 June 2022.

Postponement of CPhI & P-MEC China 2021

Due to the sudden and unexpected rise in COVID-19 cases in Shanghai and local cities, we have taken the decision to postpone the in-person CPhI & P-MEC China event from 16-18 December 2021 to 21-23 June 2022.

2021 Zhejiang Export Commodity Online Fair: Thailand & Idonesia – Natural Extracts Session is launched now!

The Zhejiang Export Commodity Online Fair (Pharma Sector) is coming with a fresh new session in 2021, with the platform functionally optimized for better user experience. The portal for the “Thailand & Indonesia – Natural Extracts Session” is officially launched to welcome the online participation of both natural extracts suppliers in Zhejiang Province of China, as well as buyers from Thailand and Indonesia.

2021 Zhejiang Export Commodity Online Fair “Australia & New Zealand – APIs Session” is launched now!

The Zhejiang Export Commodity Online Fair (Pharma Sector) is coming with a fresh new session in 2021, with the platform functionally optimized for better user experience. The portal for the “Australia & New Zealand – APIs Session” is officially launched to welcome the online participation of both fine chemical suppliers in Zhejiang Province of China, as well as buyers from Australia & New Zealand.

2021 Zhejiang Export Commodity Online Fair “USA & Canada – Fine Chemicals Session” is launched now!

The Zhejiang Export Commodity Online Fair (Pharma Sector) is coming with a fresh new session in 2021, with the platform functionally optimized for better user experience. The portal for the “USA & Canada – Fine Chemicals Session” is officially launched to welcome the online participation of both fine chemical suppliers in Zhejiang Province of China, as well as buyers from USA & Canada.

PharmaSources Launches E-Trade Season 2021 ——Digital Business Platform & On-demand Webinars for Pharmaceutical Industry

PharmaSources.com, an international B2B trade portal for the pharmaceutical verticals, is launching the virtual event E-Trade Season together with CPhI and P-MEC China from March to June 2021 to provide the pharmaceutical industry with online learning and trading opportunities. This includes months of informative content and targeted matchmaking service – delivering over 8 themed webinar series and showcasing high-quality pharma suppliers from different pharmaceutical sectors.

2021 Zhejiang Export Commodity Online Fair: Japan & Republic of Korea – Natural Extracts Session is launched now

The Zhejiang Export Commodity Online Fair (Pharma Sector) is coming with a fresh new session in 2021, with the platform functionally optimized for better user experience. The portal for the “Japan & Republic of Korea – Natural Extracts Session” is officially launched to welcome the online participation of both natural extracts suppliers in Zhejiang Province of China, as well as buyers from Japan and Republic of Korea.

Pharma Sources Insight October 2020 Focuses on Pharma Landscape in China

With over 4000 pharmaceutical companies, China is the second-largest pharmaceutical industry globally. A report by Deux Consulting shows that China is estimated to reach $161.8 billion by 2023 and take a 30% share of the global market. The October Pharma Sources Insight will provide insights into the Chinese pharmaceutical industry on the following aspects, which offers an industry landscape in China.

PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season

PharmaSources, an international B2B trade portal for the pharmaceutical verticals, is launching the virtual event CPhI & P-MEC China E-Trade Season from August to December 2020. Consisting of the three sessions “Top API Exporters & Products”, “Popular Natural Extracts for Health and Pharma” and “P-MEC China Webinar: Russia Pharmaceutical Manufacturing and Machinery”, the E-Trade Season is to facilitate digital sourcing solutions, learning opportunities and business connections for global pharmaceutical practitioners.

Meet and Trade with Qualified Business Partners on the Fourth Week of 2020 Zhejiang Export Commodity Online Fair

The 2020 Zhejiang Export Commodity Online Fair (Pharma Sector) has entered into the fourth week. The portals for the “North America – Pharma Machinery”, “India – Pharma Intermediates” and “Europe – Fine Chemicals” have now been launched to welcome the participation of both pharmaceutical suppliers located in Zhejiang Province of China, as well as European & Indian & North America buyers online.

2020 Zhejiang Export Commodity Online Fair Focuses on 3 pharma areas for European & Indian buyers this week!

The 2020 Zhejiang Export Commodity Online Fair (Pharma Sector) has entered into the third week. The portals for the “Europe – Pharma Machinery”, “Europe – Pharma Intermediates” and “India – Fine Chemicals” have now been launched to welcome the participation of both pharmaceutical suppliers located in Zhejiang Province of China, as well as European & Indian buyers online.

Sourcing from the Heated Marketplace of Zhejiang China @ Zhejiang Export Commodity Online Fair (Europe & North America – APIs)

The 2020 Zhejiang Export Commodity Online Fair (Pharma Sector) has ushered in a second week. The portals for the “Europe – APIs” and “North America – APIs” this week have now been launched separately to welcome the participation of both pharmaceutical suppliers located in Zhejiang Province of China, as well as European & North American buyers online.

How Fette Compacting China supports the Battle against COVID-19

The global pandemic of COVID-19 has changed the focus towards epidemic prevention and control of the infection in all areas of the world. The WHO is sparing no effort to call all nations to strengthen unity and cooperation to fight the epidemic disease spread. The scientific world has been searching for weeks for a coronavirus vaccine, while continuing investigations on how to treat patients. This global approach has significantly accelerated the development of therapeutic drugs for the treatment of COVID-19 infection, targeting to improve the cure rate and to reduce the death toll as top priority.

New virus cases in Wuhan expected to drop to zero by late March

New cases of novel coronavirus infection in Wuhan, Central China’s Hubei province, are expected to be zero at the end of this month, Zhang Boli, a member of the work group sent by the central government to guide epidemic control work in Hubei, said recently.

Epidemic fight in new stage

A key Party meeting on Wednesday presided over by Xi Jinping, general secretary of the Communist Party of China Central Committee, stressed the need to unleash consumer demand that has been restrained during the novel coronavirus pneumonia outbreak and continuing to expand opening-up.

New coronavirus infections continue downward trend

A total of 125 new confirmed cases of novel coronavirus infection and 31 deaths were reported on Monday on the Chinese mainland, bringing the two numbers up to 80,151 and 2,943 respectively, the National Health Commission said Tuesday morning.

China to donate epidemic prevention materials to Japan

The Chinese government will donate 5,000 sets of protective clothing and 100,000 masks to Japan in batches, the first two of which arrived in Tokyo on February 27 and 28 in order to help Japan to fight against the novel coronavirus, the Chinese Embassy in Japan said in a statement on Saturday.

Epidemic easing at its epicenter

The novel coronavirus epidemic has been easing in China, including in the epicenter city of Wuhan, in Hubei province, but great uncertainties remain and epidemic control efforts must not become lax in any case, the nation’s top health authority said on Feb 28.

Cure Rates Rising for the 19th Consecutive Day with Wuhan Exceeding 50%

At a press conference held by the State Council inter-agency task force on COVID-19 outbreak on the afternoon of 4 March, Mr. Mi Feng, a spokesperson of the National Health Commission and Deputy Director-General for Communications noted that as of 3 March, the cure rates of confirmed cases had been on the rise for the 19th consecutive day, with the figure reaching 50.2% in Wuhan, 76.8% in other parts of Hubei and 87.3% in other provinces. In the coming weeks, it is important to lock in treatment gains, further improve the therapeutic solutions, harness the strengths of both traditional Chinese medicine and western medicine, closely monitor and provide all-round care to patients in severe or critical conditions, so as to further increase the cure rate and lower the case fatality rate.

Epidemic response to be improved, expert says

The novel coronavirus pneumonia epidemic is likely to be brought under control on the Chinese mainland by the end of April, said renowned respiratory expert Zhong Nanshan, who also called for enhanced global cooperation to fight the disease.

The State Council Inter-agency Task Force: Low-risk Regions Should Resume Order of Production and Life Across the Board and Lift Travel Restrictions

On 25 February, at a press briefing of the State Council inter-agency task force on responding to the novel coronavirus pneumonia outbreak, Director General of the Department of Social Development of the National Development and Reform Commission Ou Xiaoli elaborated on the principle of region-specific, targeted resumption of work and production. Under this principle, each county, with the exception of those in Hubei Province and Beijing Municipality, will be categorized as either low-risk, medium-risk or high-risk in light of its outbreak intensity.

NHC: Cured and Discharged Cases Continue to Rise Nationwide

At the press briefing organized by the State Council inter-agency task force on COVID-19 outbreak on the afternoon of 26 February, Mi Feng, an NHC spokesperson, said that between 00:00 and 24:00, 25 February, 406 confirmed cases, 52 fatal cases (all in Hubei province) and 439 suspected cases were newly reported by the 31 provinces, autonomous regions and municipalities and the Xinjiang Production and Construction Corps.

State Council unveils new measures to mitigate coronavirus impact on Chinese economy

BEIJING — The State Council, China’s cabinet, on Feb 25 unveiled a string of measures to facilitate the employment of college graduates and rural migrant workers, offer financial support to micro-, small- and medium-sized enterprises and solve the difficulties of self-employed persons to reduce the impact of the coronavirus epidemic on the economy.

Li: New policies will help smaller businesses

China will roll out a set of strong financial policies, including encouraging financial institutions to provisionally defer loan payments and increase lending at concessional rates for micro, small and medium-sized businesses as part of supportive efforts undertaken as they resume operations amid a difficult situation.

Work resumption will keep supply chains steady: MoC

China will facilitate more foreign companies in resuming work and production amid the novel coronavirus epidemic in order to stabilize the global supply chain, a senior official of the Ministry of Commerce said on Monday.

China achieves notable results in blocking COVID-19 human-to-human transmission

BEIJING — China’s unprecedented public health responses to the COVID-19 outbreak have yielded notable results in blocking human-to-human transmission of the virus, preventing or at least delaying hundreds of thousands of cases, said a joint expert team consisting of experts from China and the World Health Organization.

China focuses on resumption of delivery

China will speed up the resumption of delivery services to aid the nation’s epidemic control and prevention efforts and make sure people can get deliveries of daily necessities amid the ongoing novel coronavirus outbreak, a senior transport official said.

NHC: New Confirmed Cases Outside Hubei Dropped From the Peak of 890 to 18 Despite Some Fluctuations

At the press briefing given by the State Council inter-agency task force on COVID-19 outbreak on the afternoon of 23 February, Mi Feng, an NHC spokesperson, said that between 00:00 and 24:00, 22 February, 18 confirmed cases, 251 suspected cases and 1 fatal case were newly reported outside Hubei and the number of severe cases down by 45. New confirmed cases dropped below five or to zero in all provinces other than Hubei. The number of new confirmed cases outside Hubei dropped from the Peak of 890 to 18 on 22 February, showing a fluctuating downward trend. 16 provinces and the Xinjiang Production and Construction Corps haven’t seen any new confirmed cases for more than two consecutive days.

Good News! Antibody Production Successfully Induced in the First Batch of Vaccines

On the afternoon of 22 February, at the 27th local press briefing on the epidemic control of the novel coronavirus disease (COVID-19) in Zhejiang Province, Song Zhiheng, deputy head of the Science and Technology Department of Zhejiang Province, said that the first batch of vaccines has successfully induced antibody production and entered the stage of animal test. The cultivation of recombinant virus for the development of recombinant adenovirus vector vaccine has started, and animal test will begin soon. In Zhejiang Province, scientists are already conducting vaccine research based on the fourth generation of the coronavirus, and they are now racing against time to seek breakthroughs. Despite these positive developments, it is important to recognize that there is a long R&D cycle for vaccines and the law of science must be respected to make sure that the research process is strictly science-based and safe.

Daily New Confirmed Cases Outside Hubei Drop Below 100 for the First Time

The Paper (www.thepaper.cn) learned from the press conference held by the State Council inter-agency task force at 15:00, 18 February that the number of new confirmed cases of the novel coronavirus pneumonia (NCP, or COVID-19) has dropped for 14 consecutive days. On 17 February, compared with the peak, for the first time, the number of daily new confirmed cases nationwide dropped below 2,000. For the first time, the number of daily new confirmed cases outside Hubei went below 100. And for the first time, the number of daily new fatal cases nationwide fell below 100. These three “first times” show that the outbreak is trending further in a positive direction.

Pharma players in action to fight COVID-19

China’s new confirmed cases of novel coronavirus pneumonia outside Hubei Province, where the epicenter city of Wuhan is located, has been dropping for 14 consecutive days, according to the National Health Commission. Till 18th Feb, 12563 patients were released from hospitals after being cured in the mainland of China, achieving an overall cure rate of 17.3% (out of 72530 total confirmed cases), compared to the rate of 1.3% on 27 January. The figures show that treatment measures are achieving effective results across the country.

First antiviral drug approved to fight coronavirus

Favilavir, formerly known as Fapilavir, an antiviral that has shown efficacy in treating the novel coronavirus, was approved for marketing, the Taizhou government in Zhejiang province announced Sunday.